Atlas Trials

Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Subjects

Clinical trial NCT05967377 · COMPLETED

Trial details

NCT number
NCT05967377
Sponsor
Xspray Pharma AB
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
PharmacokineticsBioavailability
Start date
2018-11-16
Primary completion
2019-02-12
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.